Podcast: Geneticist George Church on the future of synthetic biology

dn

George Church’s Harvard lab is one of the most celebrated fonts of innovation in the world of life sciences. George’s earliest work on the Human Genome Project arguably pre-dated the actual start of that project.

Much of George’s most recent and celebrated work has been with a transformationally powerful gene-editing technique called CRISPR, which he co-invented. George and I discuss CRISPR and its jarring ramifications throughout this week’s edition of the After on Podcast.

We begin by discussing genetic sequencing. “Sequencing” is a fancy (and rather cool way) of saying, “reading.”

George and I next discuss gene editing. As the word suggests, editing the genome of a person, bacterium, or virus involves changing some of its letters.

The third thing we discuss is DNA synthesis. Specifically, the creation of relatively small, customized units called “oligos.” These are short sequences of DNA, which typically run from a couple dozen letters to a couple hundred letters long.

Our fourth topic is DNA assembly. This is the process of stringing those oligos together into long strands.

So that’s the table of contents of the first half of our interview: Sequencing, editing, synthesis, and assembly. With those foundations in place, George and I then talk about the astounding things that this integrated set of rapidly improving, and mutual reinforcing fields are enabling.

Read full, original post: The astounding present and dizzying future of synthetic biology

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-04-22-at-12.21.32-PM
Viewpoint: Why the retracted Monsanto glyphosate study doesn’t change the science—the world’s most popular herbicide is safe 
Picture1
The FDA couldn’t find a vaccine safety crisis, so it buried its own research
ChatGPT-Image-May-1-2026-11_42_59-AM-2
Viewpoint: NAD is the wellness grifters latest evidence-lite longevity fad. At least the mice are impressed.
global warming
‘Implausible’: Top climate scientists reject worst-case scenario—soaring temperatures and fast-rising sea levels
Screenshot-2026-05-21-at-12.15.17-PM
UK gene-editing milestone: Livestock barley that increases ruminant value and reduces methane emissions is first-approved CRISPR crop
vax-misinformation-main
Facts & Fallacies Podcast: Limit free speech to blunt social media misinfo?
Screenshot-2026-05-21-at-3.15.53-PM
Chiropractors may no longer be modern-day snake oil salesmen, but the benefits of their therapy are limited–at best
ChatGPT-Image-Apr-16-2026-02_56_53-PM
Financial incentives, over diagnosis, and weak oversight: Autism claims are driving up Medicare costs
ChatGPT-Image-May-12-2026-11_27_01-AM-2
AI likely to improve health care, research shows—but not for blacks and ethnic minorities
Screenshot-2026-05-20-at-5.11.17-PM
Viewpoint: No, sugar doesn’t ‘feed’ cancer — common cancer myths, debunked

Sorry. No data so far.

glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.